Screening of small molecular microbial products modulating immune responses and bestatin.

Screening of small molecular microbial products modulating immune responses and bestatin. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Screening of small molecular microbial products modulating immune responses and bestatin. Abstract Text:

H Umezawa,

Microorganisms are the treasury of organic compounds which have various structures and various biologic and medicinal activities. The study of inhibitors of enzymes on the cellular surface has led to the findings of immunomodulators; bestatin, amastatin, forphenicine, and esterastin. Bestatin enhances delayed-type hypersensitivity to SRBC and oxazolone and inhibits Gardner lymphosarcoma and IMC-carcinoma in mice. It also suppressed Ps. aeruginosa infection in mice treated with an immunosuppressive agent. Bestatin has extremely low toxicity and has been studied clinically. These studies on bestatin were reviewed.

Screening of small molecular microbial products modulating immune responses and bestatin. Publishing Authors By Initials

H Umezawa,

For similar neoplasms: neoplasms, experimental research abstracts see: neoplasms: neoplasms, experimental research

PUBMED ID PMID:

MEDLINE DATE:

Screening of small molecular microbial products modulating immune responses and bestatin. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Recent results in cancer research. Fortschritte de

VOLUME: 75

Page Numbers: 115-25

Journal Abbreviation: Recent Results Cancer Res.

ISSN: 0080-0015

DAY: 13

MONTH: 02

YEAR: 1980

Screening of small molecular microbial products modulating immune responses and bestatin. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 44671

Screening of small molecular microbial products modulating immune responses and bestatin. Keywords Mesh Terms:

KEYWORDS: Neoplasms, Experimental

MESH TERMS: drug therapy

Chemical & Substance for Abstract: Screening of small molecular microbial products modulating immune responses and bestatin. Information

Substance Name: Aminopeptidases

Registry Number: EC 3.4.11.-

Grant and Affiliation Information for Screening of small molecular microbial products modulating immune responses and bestatin.

AFFILIATION:

Country: GERMANY, WEST

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Recent Results Cancer Res

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Screening of small molecular microbial products modulating immune responses and bestatin Related Publications

• A genetic method to identify mitochondrial proteins in living Mammalian cells.
• Bleomycin and other antitumor antibiotics of high molecular weight.
• Current status of Japanese studies with the new anthracycline antibiotic aclacinomycin A.
• Fundamental studies on bestatin: a small molecular microbial product enhancing immune response.
• Hyaline cartilage formation and enchondral ossification modeled with KUM5 and OP9 chondroblasts.
• Identification of proteins targeted into the endoplasmic reticulum by cDNA library screening.
• Inhibition of CDP-DG: inositol transferase by inostamycin.
• Inhibition of G1 cyclin expression in normal rat kidney cells by inostamycin, a phosphatidylinositol synthesis inhibitor.
• Inhibition of nucleic acid biosynthesis in cell-free systems of Escherichia coli B by pluramycin.
• Inhibition of protein synthesis by bottromycin A2 and its hydrazide.
• Kinetic studies on the inhibition of nucleoside diphosphate kinase by desdanine.
• Local-density approximation for orbital densities applied to the self-interaction correction.
• Mechanism of kasugamycin action on polypeptide synthesis.
• Messenger RNA-associated 30S ribosomal subunit: extraction from E. coli and the effect of chloramphenicol on the content.
• Mode of action of enomycin, an antitumor antibiotic of high molecular weight. 3. On the weak inhibition of polyphenylalanine synthesis directed by polyuridylic acid.
• Mode of action of enomycin, an antitumor antibiotic of high molecular weight. I. Inhibition of protein synthesis.
• Mode of action of enomycin, an antitumor antibiotic of high molecular weight. II. Preferential binding of enomycin to mammalian ribosomes.
• NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor.
• Natural and artificial bleomycins: chemistry and antitumor activities.
• New anthracycline antibiotic aclacinomycin A: experimental studies and correlations with clinical trials.
• New microbial secondary metabolites under preclinical development for cancer treatment.
• Optical probes to identify the glucocorticoid receptor ligands in living cells.
• Pyruvate kinase of Escherichia coli. Its role in supplying nucleoside triphosphates in cells under anaerobic conditions.
• Screening of small molecular microbial products modulating immune responses and bestatin.
• Studies on antitumor substances of microbial origin.
• The subunit composition of hinokiresinol synthase controls geometrical selectivity in norlignan formation.
• Ways for a mesenchymal stem cell to live on its own: maintaining an undifferentiated state ex vivo.
• [Method for determination of the bleomycin inactivating enzyme acitivity in tissues]
• [Screening of bioactive metabolites that suppress inflammation]
• [Uptake and translocation of 14C-labelled Kasugamycin in rice plants]